Intracellular pathogens such as Mycobacterium tuberculosis are able to survive in the face of antimicrobial products generated by the host cell in response to infection. The product of the alkyl hydroperoxide reductase gene (ahpC) of M. tuberculosis is thought to be involved in protecting the organism against both oxidative and nitrosative stress encountered within the infected macrophage. Here we report that, contrary to expectations, ahpC expression in virulent strains of M. tuberculosis and Mycobacterium bovis grown in vitro is repressed, often below the level of detection, whereas expression in the avirulent vaccine strain M. bovis BCG is constitutively high. The repression of the ahpC gene of the virulent strains is independent of the naturally occurring lesions of central regulator oxyR. Using a green fluorescence protein vector (gfp)-ahpC reporter construct we present data showing that repression of ahpC of virulent M. tuberculosis also occurred during growth inside macrophages, whereas derepression in BCG was again seen under identical conditions. Inactivation of ahpC on the chromosome of M. tuberculosis by homologous recombination had no effect on its growth during acute infection in mice and did not affect in vitro sensitivity to H 2 O 2 . However, consistent with AhpC function in detoxifying organic peroxides, sensitivity to cumene hydroperoxide exposure was increased in the ahpC::Km r mutant strain. The preservation of a functional ahpC gene in M. tuberculosis in spite of its repression under normal growth conditions suggests that, while AhpC does not play a significant role in establishing infection, it is likely to be important under certain, as yet undefined conditions. This is supported by the observation that repression of ahpC expression in vitro was lifted under conditions of static growth.
The success of Mycobacterium tuberculosis as a human pathogen is based on its ability to survive and grow within macrophages. Following infection, the bacteria are phagocytosed at the site of entry, usually in the lungs. M. tuberculosis survives this initial interaction with macrophages and may either grow to cause primary tuberculosis or enter a state of latency in which it can persist, sometimes for decades, within lung macrophages or other sites. Thus, while it is estimated that over 1 billion people are infected with M. tuberculosis worldwide (World Health Organization tuberculosis fact sheet [http://www.int]), only approximately 5 to 15% of the exposed individuals who undergo tuberculin conversion develop primary tuberculosis. The majority remain latently infected and run a 10% lifetime risk of developing active disease (33, 40) . Latently infected individuals contribute to the persistence of M. tuberculosis in the population and affect the global tuberculosis control efforts. The sequencing and analysis of the complete M. tuberculosis genome (9) have made possible considerable progress in addressing the molecular basis of mycobacterial virulence. However, our understanding of how the organism survives in the face of hostile innate and acquired immune responses to produce primary disease and of the molecular basis for the establishment and maintenance of latency and for subsequent disease reactivation is far from complete.
M. tuberculosis infects macrophages and persists in granulomatous lesions in the host, where the bacilli are exposed to reactive oxygen intermediates (ROI) (11, 20, 44) and reactive nitrogen intermediates (6, 18, 26, 28, 30, 35 ) (RNI). The initial studies of the oxidative and nitrosative stress response in mycobacteria have yielded the paradoxical finding that the oxidative stress response is partially dysfunctional in the two most important mycobacterial pathogens, M. tuberculosis and Mycobacterium leprae (13-15, 27, 48) . The M. tuberculosis equivalent of oxyR (13, 15, 39) , the central regulator of the peroxide stress response (2, 8) , which also acts as a regulator of the nitrosative stress response (21) , has been shown to be a pseudogene, inactivated via multiple lesions (Fig. 1A) . Similarly, the furA and katG genes of M. leprae are vestigial and carry multiple mutations (9, 14, 27, 32) .
Despite the loss of oxyR in M. tuberculosis and inactivation of furA and katG in M. leprae, several oxidative stress response genes are preserved in the tubercle and leprosy bacilli. One such gene, ahpC (9, 13, 23, 39, 48) , encodes a subunit of an enzyme that detoxifies organic peroxides (25, 39) and possibly hydrogen peroxide (29) . AhpC has been implicated in nitric oxide metabolism using heterologous systems (7) . In the majority of mycobacterial species ahpC is expressed at normal levels (17, 32, 34, 49) . However, the levels of AhpC in M. tuberculosis are usually undetectable or very low (17, 46, 51) , although, according to some reports, AhpC can be detected in the tubercle bacillus (7) . In mycobacterial species with a functional oxyR gene, OxyR binds to the ahpC promoter (15, 32, 44) . Insertional inactivation of oxyR in Mycobacterium marinum results in reduced ahpC expression and abrogates its ability to respond to induction by exposure to hydrogen peroxide (Pagan-Ramos and Deretic, unpublished data). These studies support the notion that the loss of oxyR contributes to the low expression of ahpC in the tubercle bacillus. Nevertheless, the preservation of ahpC in M. tuberculosis suggests that, despite silencing, it plays a role in the physiology of this organism.
Here we extend our investigations of the silencing of ahpC in M. tuberculosis. We report a second level of ahpC regulation in the tubercle bacillus and the loss of repression in avirulent vaccine strain BCG. We also present data on in vivo expression of ahpC in infected macrophages and on the effect of targeted deletion of ahpC on the ability of M. tuberculosis H37Rv to produce acute infection in mice.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and in vivo stability of M. tuberculosis H37Rv. M. tuberculosis and Mycobacterium bovis strains were from the American Type Culture Collection unless stated otherwise. Plasmids were introduced into mycobacteria as previously described (24) . The construction and properties of M. tuberculosis H37Rv*, which overexpresses plasmid-borne ahpC, have been previously described (17) . Mycobacteria were grown under aerated conditions or in static culture as previously described (45) .
Insertional inactivation of ahpC in M. tuberculosis via homologous recombination. The ahpC gene was inactivated using a previously published strategy for gene replacements in mycobacteria (36, 37) . A BamHI fragment (H37Rv genomic coordinates 2723977 to 2729394) containing M. tuberculosis ahpC (cloned on a pBluescript plasmid containing wild-type rpsL from M. tuberculosis; vector ptrpA-1-rpsL ϩ ) was subjected to ahpC inactivation with a Km r cassette by its insertion into the EcoRI site of ahpC (location 2726263 to 2726460). The nonreplicative plasmid was introduced into Str r M. tuberculosis H37Rv by electroporation, and Km r colonies were screened by Southern blot analysis for single-crossover recombinants. Positively identified strains with the plasmid integrated on the chromosome via homologous recombination events were subjected to counterselection against rpsL, carried by the vector moiety, by plating on media containing streptomycin. Str r colonies were subjected to Southern blot analysis, and recombinants that underwent second crossover events were identified as strains with ahpC::Km r gene replacements. GFP fusions, macrophage infection, flow cytometry, and antibodies for Western blot analyses. The ahpC-gfp and hsp60-gfp fusions and the gfp vector have been previously reported and characterized (16) . Macrophage infection with mycobacteria passed through a 5-m-pore-size filter to ensure removal of clumps and flow-cytometric analysis were carried out as previously described (16, 43) . Flow cytometry of formaldehyde-fixed green fluorescence protein (GFP)-labeled mycobacteria, released from macrophages as described previously (16) , was carried out in a Becton Dickinson FACSCAN, and data were analyzed by Lysis II software. The rabbit polyclonal antibody raised against purified M. tuberculosis AhpC has been previously reported (32) . The rabbit polyclonal antibody raised against a KatG peptide was from C. Barry.
Mouse model of tuberculosis infection. The wild-type strain and single-crossover and ahpC-deleted mutant strains of M. tuberculosis H37Rv Str r were grown in Dubos 7H9 broth for 14 days. Each strain was diluted in phosphate-buffered saline to give a suspension of approximately 2.5 ϫ 10 5 CFU per ml, and 0.2 ml of these suspensions was inoculated intravenously (31) into 6-to 8-week-old female BALB/c mice. The infection was monitored by removing the lungs and spleens of infected mice and homogenizing them by shaking with 2-mm-diameter (45) are shown. Extracts were prepared, and Western blot analysis was carried out with KatG or AhpC antibodies.
glass beads in chilled saline with a Mini-Bead Beater (Biospec Products, Bartlesville, Okla.). Serial 10-fold dilutions of the resultant suspensions were plated onto Dubos 7H11 agar with Dubos oleic albumin complex supplement (Difco Laboratories, Surrey, United Kingdom). The numbers of CFU were determined after the plates had been incubated at 37°C for 20 days.
Sensitivity to compounds and survival in macrophages. Statically grown cultures of H37Rv and H37Rv ahpC::Km r were allowed to reach stationary phase (about 3 weeks) in 7H9 broth. One milliliter of each culture was added individually to 4 ml of 7H9 broth and allowed to settle for 1 week before cumene hydroperoxide (Sigma Chemicals) or hydrogen peroxide (Sigma Chemicals) was added at the concentrations indicated in the legend for Fig. 5 . The optical density at 600 nm (OD 600 ) was determined immediately following addition of agents and on the third and seventh days following treatment.
Statistical analysis. Analysis of variance and post hoc analyses were performed using SuperANOVA (version 1.11; Abacus Concepts).
RESULTS
Low levels of ahpC expression in virulent M. tuberculosis. Our previous work using antibodies against heterologous AhpC suggested that levels of AhpC are very low or below detection limits in M. tuberculosis H37Rv (17). Here we used an antibody raised against M. tuberculosis AhpC (32) to compare the relative levels of ahpC expression in different M. tuberculosis strains. Very low levels of AhpC (or its apparent absence) were observed in M. tuberculosis strains H37Rv, Erdman, and CSU #93 (Fig. 1B) . Similar silencing of ahpC expression was observed in virulent strain M. bovis Ravenel and the M. bovis type strain, ATCC 19210 (Fig. 1B) . AhpC was detectable in the previously constructed (17) derivative of M. tuberculosis H37Rv (termed H37Rv*), which differs from H37Rv only in harboring a plasmid-borne ahpC gene (Fig. 1B, lane 1) .
The very low level of ahpC expression in virulent M. tuberculosis complex strains could be attributed to the loss of oxyR in the tubercle bacillus (12, 14) . However, our recent inactivation of oxyR in M. marinum (Pagan-Ramos and Deretic, unpublished data) has suggested that, while induction of ahpC is impaired in the oxyR mutant, the steady-state levels of ahpC remained relatively high and unchanged under normal growth conditions. Thus, the finding of very low levels of detectable AhpC in M. tuberculosis was difficult to explain by the loss of oxyR alone. To test the possibility that this phenomenon could be due to an additional process of active repression, we introduced into M. tuberculosis H37Rv the ahpC-oxyR intergenic region containing the ahpC promoter (17) on a plasmid and examined chromosomal ahpC expression by monitoring AhpC levels by Western blotting. We detected increased levels of AhpC in the strain harboring extra copies of the plasmid-borne ahpC promoter/operator region (Fig. 1C, lanes 1 and 2) , indicating that the chromosomal copy of ahpC was derepressed, possibly due to a multicopy titration of a negative regulatory element(s), e.g., a transcriptional repressor. These observations suggest that ahpC may be actively silenced in M. tuberculosis via repression mechanisms in addition to the effects of the loss of activator oxyR. In search of conditions that may derepress ahpC in virulent strains, we found that growth of M. tuberculosis H37Rv under static conditions induced production of significantly higher levels of AhpC (Fig. 1D , lanes S) than growth under oxygenated conditions. The effect was specific for AhpC, as KatG levels did not change (Fig. 1D) .
Loss of ahpC repression in avirulent vaccine strain BCG. A similar set of experiments was carried out with M. bovis BCG (Pasteur). In contrast to various strains of M. tuberculosis, M. bovis BCG showed high levels of AhpC expression even in the absence of the repressor-titrating plasmid construct (Fig.  1C, lane 3) , and expression of AhpC was only slightly increased in the strain harboring the oxyR-ahpC promoter/operator region. We next investigated different BCG strains and observed high levels of AhpC (Fig. 1B, lanes 7 to 9) compared to those for M. tuberculosis (Fig. 1B, lanes 2 to 4) . Although levels of AhpC were relatively high in all BCG strains, they were low or undetectable in the parent organism, M. bovis (Fig. 1B, lanes 5  and 6) . A recent study (3) suggested that BCG Russia (ATCC 35740) is probably the BCG strain that is the closest to the original strain of BCG derived from virulent M. bovis. BCG Russia also showed high levels of AhpC (Fig. 1B, lane 7) , suggesting that the deregulation of ahpC expression in BCG is a property of all BCG strains. Thus, the mutation(s) causing overexpression of ahpC occurred early in the BCG lineage and most likely emerged during passages that led to avirulence of M. bovis BCG.
In vivo silencing of ahpC in M. tuberculosis H37Rv and expression in M. bovis BCG during macrophage infection. The experiments described in the previous sections suggest that ahpC repression in virulent strains may be an important aspect of M. tuberculosis biology and pathogenesis. However, the Western blot data were obtained using bacteria cultured in vitro. To test whether the silencing of ahpC observed in vitro also takes place in vivo, we examined ahpC expression in infected macrophages using GFP as a reporter of transcriptional activity (16) . M. tuberculosis H37Rv and M. bovis BCG strains carrying the ahpC-gfp (Fig. 1A) or hsp60-gfp (16) transcriptional fusions were used to infect macrophages. The promoter activities were monitored by flow cytometry after 3 days of infection. The results ( Fig. 2A and C to E) indicate that, whereas the hsp60 promoter was active (positive control), the ahpC promoter was inactive or was expressed below detection limits in M. tuberculosis H37Rv during macrophage infection. In contrast, the activity of the ahpC-gfp fusion in BCG exceeded that of strong promoter fusion hsp60-gfp (Fig. 2F to H) . Hence, repression (silencing) of ahpC in virulent M. tuberculosis occurs in vivo during intraphagosomal growth, while ahpC is derepressed in BCG in infected macrophages.
Inactivation of ahpC in M. tuberculosis H37Rv by homologous recombination and analysis of infection in mice.
The silencing of ahpC during in vitro growth or in infected macrophages suggests that AhpC may not play a major role in M. tuberculosis in resistance against host-generated protective mechanisms during infection. To test this possibility, we inactivated the ahpC gene on the chromosome of M. tuberculosis H37Rv via homologous recombination using a selection procedure described in Materials and Methods. Southern blot hybridization analyses carried out with the parental ahpC ϩ strain of M. tuberculosis H37Rv, single-crossover intermediates, and the final ahpC::Km r strain demonstrated that a true gene replacement had taken place (Fig. 3A) . Western blot analyses also confirmed that, while KatG levels were unchanged (Fig. 3B) , there was no detectable AhpC product in the ahpC knockout strain ( Fig. 3C ; the protein extracts were prepared from cells grown under conditions permitting induction of ahpC in M. tuberculosis H37Rv as in Fig. 1D) (Fig. 4) . The apparent minor inferiority of the ahpC ϩ parental strain was, however, not seen with the ahpC ϩ ahpC::Km r merodiploid intermediate, which showed a growth pattern identical to that of the ahpC mutant. Thus, we conclude that ahpC inactivation does not reduce the virulence of the tubercle bacillus in the murine model of tuberculosis.
AhpC role in protection against peroxide toxicity. Despite the apparent silencing of ahpC in virulent M. tuberculosis, the preservation of an intact ahpC gene indicates that it confers a selective advantage under some circumstances encountered by the organism. The results presented previously (Fig. 1D) indicate that growth of M. tuberculosis under static conditions is associated with increased expression of ahpC. We therefore investigated the functional relevance of AhpC production during static incubation by exposing the ahpC ϩ parental strain of M. tuberculosis and the isogenic ahpC::Km r mutant strain to different concentrations of organic peroxide cumene hydroperoxide and hydrogen peroxide under different aeration conditions. In aerated cultures, consistent with low levels of ahpC expression, no differences in sensitivity to peroxides were detected (data not shown). Under static conditions of growth, we observed increased sensitivity, specifically to organic peroxide cumene hydroperoxide, in the ahpC::Km r mutant compared to the ahpC ϩ parent (Fig. 5A) . No detectable differences between the wild-type and ahpC::Km r strains in sensitivity to hydrogen peroxide were observed (Fig. 5B ).
DISCUSSION
The mechanisms by which M. tuberculosis is able to survive and grow within the hostile environment of a host macrophage are likely to be complex and multifactorial. In addition to the ability of the bacteria to influence their microenvironment within the phagosome (1, 19, 41) , the ability of M. tuberculosis to produce agents which counter the toxicity of antimicrobial products produced by activated macrophages is thought to be important. There is considerable evidence that the production of RNI and/or ROI by macrophages is important in the generation of effective immunity against mycobacteria (6, 11, 18, 20, 26, 28, 30, 35, 44) . Thus, detoxification of RNI and ROI by the bacteria is expected to influence their intracellular survival. Several genes in the M. tuberculosis genome which encode proteins thought to be involved in protection against RNI and/or ROI have been identified (9) . In this study we have focused on one such gene, ahpC. This gene was chosen because of its reported role in the virulence of another member of the M. tuberculosis complex, M. bovis (46) , and because of the role of AhpC in detoxifying organic peroxides (25, 39) , hydrogen peroxide (29) , and RNI (4, 7).
Our results with the ahpC::Km r strain of M. tuberculosis, which carries an insertionally inactivated ahpC gene, indicate that AhpC plays no significant role during the acute-infection phase of mice. This is compatible with similar experiments with Salmonella enterica serovar Typhimurium, in which inactivation of ahpC had no effect on virulence in BALB/c mice (42) . Similarly, up-regulation of ahpC in a strain of M. tuberculosis which had lost KatG activity did not result in increased virulence in mice (22) , again suggesting that AhpC is not involved in virulence, at least during the acute phase of infection. These results are in contrast to those of Wilson et al. (46) , who used an antisense RNA strategy to down-regulate ahpC expression in M. bovis and found significantly decreased virulence in guinea pigs. These discrepancies may be explained by different methodologies used to generate a null mutant or phenotype, differences in virulence determinants between M. tuberculosis and M. bovis in spite of their close sequence similarity, or different animal models used to evaluate virulence.
Our results demonstrating a very low level of ahpC expression in M. tuberculosis and M. bovis, contrasting with the high level of ahpC expression in BCG, both in vitro and during growth in macrophages, also appear to argue against an overt role in virulence. Nevertheless, the retention of a functional ahpC gene by M tuberculosis in spite of the loss of oxyR, the gene encoding the major regulator of ahpC, suggests that a functional ahpC must confer some selective advantage. It is also noteworthy that M. leprae, a closely related pathogen which has undergone considerable genome downsizing, has retained functional ahpC and oxyR genes (10) . The facts that we found elevated levels of expression of ahpC in static cultures compared to those in aerated cultures and that in static cultures the ahpC::Km r strain of M. tuberculosis was more sensitive to organic peroxides lend support to the idea that there are environmental conditions for which AhpC production is advantageous. Whether such conditions are important during the infection cycle of M. tuberculosis remains to be determined.
While the lack of a functional oxyR gene in M. tuberculosis could explain the very low levels of ahpC expression, the regulation of ahpC in mycobacteria does not appear to simply involve the binding of OxyR to the ahpC promoter. Introduction of the plasmid-borne ahpC-oxyR intergenic region results in increased production of AhpC in M. tuberculosis, consistent with the presence of a transcriptional repressor. In addition, M. bovis BCG also lacks oxyR, as is the case with all other members of the M. tuberculosis complex (12, 14) . Thus, differences in ahpC expression between BCG and virulent M. bovis cannot be attributed to the loss of oxyR. Overexpression of ahpC has been associated in some strains of M. tuberculosis and M. bovis with mutations in the ahpC promoter (17, 38, 51) . We (Fig. 1A) . The corresponding alanine residue is highly conserved in all FurA homologues, as shown in multiple sequence alignments of mycobacterial FurA (32), including the newly reported Mycobacterium smegmatis FurA (50) . FurA missense mutations in the corresponding regions of PerR have been found to affect its repressor function and result in derepression of ahpC in B. subtilis (5) . Thus, derepression of ahpC in M. bovis BCG could be the result of the A43V mutation in the furA gene.
The results reported here demonstrate that M. tuberculosis regulates expression of AhpC. In spite of the previous failure to produce a targeted deletion of the ahpC gene in members of the M. tuberculosis complex (47), ahpC is not an essential gene for M. tuberculosis, and the protein does not appear to play a significant role in establishing infection in mice. Nevertheless, the conservation of a functional ahpC gene, the ability to regulate its expression, the increased production of the gene product during specific conditions of in vitro growth, and its ability to protect the organism against the toxic activity of organic peroxides all point to a significant role in the physiology of M. tuberculosis.
